Colfax, a supplier of fluid handling products including pumps and specialty valves, announced terms for its IPO in a filing with the SEC on Wednesday. The company plans to offer 18.8 million shares at a range of $15-$17, with insiders selling 58% of the total. Colfax has applied to list on the NYSE under the ticker CFX. Merrill Lynch, Lehman Brothers and UBS Investment Bank are the lead underwriters on the deal.